{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:33:47Z","timestamp":1771666427144,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.jns.2004.07.011","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T18:27:23Z","timestamp":1095186443000},"page":"91-98","source":"Crossref","is-referenced-by-count":37,"title":["Neurophysiological and immunohistochemical studies on Guillain-Barr\u00e9 syndrome with IgG anti-GalNAc-GD1a antibodies\u2014effects on neuromuscular transmission"],"prefix":"10.1016","volume":"225","author":[{"given":"Kyoji","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iku","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Ariga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiide","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2004.07.011_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.410230503","article-title":"Serum antibodies to gangliosides in Guillain-Barr\u00e9 syndrome","volume":"23","author":"Ilyas","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.07.011_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","article-title":"Immunopathogenesis and treatment of the Guillain-Barr\u00e9 syndrome\u2014Part I","volume":"18","author":"Hartung","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2004.07.011_bib3","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","article-title":"Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis","volume":"40","author":"Yuki","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.07.011_bib4","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.07.011_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.410350217","article-title":"The clinical correlates of high-titer IgG anti-GM1 antibodies","volume":"35","author":"Kornberg","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.07.011_bib6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.07.011_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/1531-8249(199906)45:6<758::AID-ANA10>3.0.CO;2-N","article-title":"Anti-GalNAc-GD1a antibody-associated Guillain-Barr\u00e9 syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance","volume":"45","author":"Hao","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.07.011_bib8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1212\/WNL.53.9.2122","article-title":"Rapidly progressive, predominantly motor Guillain-Barr\u00e9 syndrome with anti-GalNAc-GD1a antibodies","volume":"53","author":"Ang","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.07.011_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","article-title":"Guillain-Barr\u00e9 syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a","volume":"123","author":"Kaida","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jns.2004.07.011_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(96)00142-7","article-title":"Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barr\u00e9 syndrome subsequent to Campylobacter jejuni enteritis","volume":"71","author":"Yuki","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2004.07.011_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0165-5728(00)00451-3","article-title":"Guillain-Barr\u00e9 syndrome with IgM antibody to the ganglioside GalNAc-GD1a","volume":"113","author":"Kaida","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2004.07.011_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(91)90379-A","article-title":"Early events of chemical transmission of newly formed neuromuscular junctions in monolayers of human muscle cells co-cultured with fetal rat spinal cord explants","volume":"538","author":"Michikawa","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2004.07.011_bib13","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1212\/WNL.38.12.1890","article-title":"Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease","volume":"38","author":"Schluep","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.07.011_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.07.011_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/brain\/124.5.893","article-title":"Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal","volume":"124","author":"O'Hanlon","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jns.2004.07.011_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ana.410440610","article-title":"Neuromuscular blockade by IgG antibodies from patients with Guillain-Barr\u00e9 syndrome: a macro-patch-clamp study","volume":"44","author":"Buchwald","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.07.011_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(01)00373-3","article-title":"IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release","volume":"119","author":"Ortiz","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2004.07.011_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1023\/B:NERE.0000021239.86287.a3","article-title":"Effect of anti-rabbit asialo-GM1(GA1) polyclonal antibodies on neuromuscular transmission and acetylcholine-induced action potentials\u2014neurophysiological and immunohistochemical studies","volume":"29","author":"Taguchi","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jns.2004.07.011_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/01.WNL.0000081229.88862.C6","article-title":"GalNAc-GD1a in human peripheral nerve. Target sites of anti-ganglioside antibody","volume":"61","author":"Kaida","year":"2003","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:26:27Z","timestamp":1549239987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X04002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":19,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0022510X04002321"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2004.07.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}